ESR1 and breast cancer: More recently, it was reported that tranilast, an anti-allergic agent, attenuates Ca2+ influx and cytosolic Ca2+ oscillations evoked by insulin-like growth factor-1 (IGF-1) in the ER+ (estrogen receptor positive) breast cancer MCF7 cell line.